COVID–19 Access to Testing and Support for Immune Response Research Act of 2021
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
COVID-19 Access to Testing and Support for Immune Response Research Act of 2021
This bill requires the Centers for Medicare & Medicaid Services to provide for coverage during the COVID-19 public health emergency of T-cell diagnostic laboratory tests for individuals with a current or prior COVID-19 infection. In addition, the Department of Health and Human Services must develop a national strategy to research the immune response to COVID-19 and may award research grants.
Referred to the Subcommittee on Health.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 5745: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-5745/
"H.R. 5745: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-5745/.
H.R. 5745, 117th Cong. (2026), https://openamerica.io/bill/117-HR-5745/.
[H.R. 5745: COVID–19 Access to Testing and Support for Immune Response Research Act of 2021](https://openamerica.io/bill/117-HR-5745/)